WallStSmart
LNSR

LENSAR Inc

NASDAQ: LNSR · HEALTHCARE · MEDICAL DEVICES

$5.83
+0.00% today

Updated 2026-06-03

Market cap
$67.78M
P/E ratio
P/S ratio
1.18x
EPS (TTM)
$-0.55
Dividend yield
52W range
$5 – $13
Volume
0.1M

LENSAR Inc (LNSR) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20182019202020212022202320242025
Operating cash flow$-1.89M$-12.59M$-13.79M$-8.97M$-14.86M$-9.66M$-2.27M$-14.83M
Capital expenditures$3.25M$2.09M$366000.00$354000.00$115000.00$236000.00$156000.00$83000.00
Depreciation
Stock-based comp$1.32M$102000.00$9.04M$6.87M$6.61M$5.54M$2.67M$3.14M
Free cash flow$-5.13M$-14.68M$-14.16M$-9.32M$-14.97M$-9.89M$-2.43M$-14.91M
Investing cash flow
Financing cash flow
Dividends paid$198000.00$31000.00$1.86M$0.00
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

What is LENSAR Inc's revenue?

LENSAR Inc's trailing twelve-month revenue is $57.70M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is LNSR?

In its most recent fiscal year, LNSR ran a gross margin of 46.41%, an operating margin of -42.06%, and a net margin of -58.66%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does LNSR generate?

LNSR produced $-14.91M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is LNSR's balance sheet healthy?

LNSR holds $12.97M in cash and equivalents against — in long-term debt, on $-26.02M of shareholder equity. That debt is best read against the cash flow the business throws off each year.